Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Other Publications
    • ajnr

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.


AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

Research ArticleHead & Neck

Peritumoral Signal on Postcontrast FLAIR Images: Description and Proposed Biomechanism in Vestibular Schwannomas

John C. Benson, Matt L. Carlson and John I. Lane
American Journal of Neuroradiology October 2023, 44 (10) 1171-1175; DOI: https://doi.org/10.3174/ajnr.A7979
John C. Benson
aFrom the Department of Radiology (J.C.B., J.I.L.), Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John C. Benson
Matt L. Carlson
bDepartment of Otolaryngology-Head and Neck Surgery (M.L.C.), Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matt L. Carlson
John I. Lane
aFrom the Department of Radiology (J.C.B., J.I.L.), Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John I. Lane
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: Anecdotally, postcontrast FLAIR images of vestibular schwannomas can show peritumoral hyperintense signal, hypothesized to represent gadolinium extravasation. This study assessed the incidence of this phenomenon in a cohort of patients with treatment-naïve sporadic vestibular schwannomas.

MATERIALS AND METHODS: A retrospective review of 20 patients with presumed vestibular schwannoma based on characteristic imaging findings and with dedicated internal auditory canal imaging, including postcontrast T1W1 and postcontrast FLAIR, was performed. Tumor size and location were recorded, as was the presence or absence of a fundal fluid cleft. Images were reviewed for the presence of peritumoral hyperintense signal on FLAIR images (a “halo”) and for both subjectively and objectively elevated signal in the ipsilateral cochlea and fundus.

RESULTS: Patients were randomly selected from an institutional vestibular schwannoma registry. Eleven (55.0%) were women. A peritumoral halo was present in 90% of patients, averaging 1.0 (SD, 0.2) mm in thickness. The maximum mean FLAIR signal in the ipsilateral fundus (205.9 [SD, 110.2]) was significantly greater than on the contralateral side (121.6 [SD, 27.8]) (P = .02). Maximum mean ipsilateral intracochlear signal (167.8 [SD, 104.5]) was also significantly greater than on the contralateral side (113.4 [SD, 40.1]) (P = .04).

CONCLUSIONS: A peritumoral halo on postcontrast FLAIR images was present in 90% of our cohort with randomly selected, treatment-naïve sporadic vestibular schwannomas. Although its mechanism is unknown, this signal is hypothesized to represent gadolinium extravasation, given an ipsilateral increased signal in the adjacent internal auditory canal fundus and cochlea.

ABBREVIATIONS:

CPA
cerebellopontine angle
IAC
internal auditory canal
VS
vestibular schwannoma

Vestibular schwannomas (VSs) are benign nerve sheath neoplasms that account for approximately 80% of cerebellopontine angle (CPA) tumors in adults.1 The lifetime prevalence of developing a VS is 1 in 500.2 Even small tumors may lead to ipsilateral nonfunctional hearing and tinnitus, while medium and large-sized vestibular schwannomas may result in additional symptoms such as trigeminal neuropathy or neuralgia or brainstem compression with attendant hydrocephalus.3 VSs that grow with time have been shown to exhibit higher levels of intratumoral inflammation.4 Although physical compression from a growing tumor adequately explains the mechanism of trigeminal symptoms and noncommunicating hydrocephalus, even very small tumors that do not fill the cross-diameter of the internal auditory canal (IAC) (ie, do not compress the cochlear nerve) are often associated with progressive sensorineural hearing loss. Moreover, many studies indicate that the degree of hearing loss is poorly associated with tumor size at diagnosis,5 and progressive hearing loss is expected to occur even in tumors that do not exhibit growth.6

The imaging appearance of VSs has been extensively reported. In general, the tumors tend to extend from the IAC into the CPA, often with an “ice cream cone” configuration.7 VSs typically demonstrate homogeneous tumoral enhancement, though 5%–15% may have intratumoral cystic changes.8 Intratumoral hemorrhage, too, may be present; one study found microhemorrhages on T2*-weighted imaging in >90% of tumors.9 Compressive edema of the brachium pontis, cerebellum, and/or brainstem is observed in 5% of cases.10 In the past decade, there has been growing interest in changes of fundal fluid and labyrinthine fluid signal in association with vestibular schwannomas.11 Previous studies have demonstrated that increased FLAIR signal and decreased T2 signal occur in many cases and correlate with the development of progressive hearing loss.12 There are also studies examining early and delayed gadolinium signal in the fundus and labyrinth.13 The mechanisms behind this phenomenon remain unknown but may include buildup of endogenous proteins and metabolites (“biologic pollution”) from trapped CSF, increased permeability of the blood-labyrinthine barrier, activation of an inflammatory cascade, and/or tumor “shedding” or “leaking.”

Anecdotally, peritumoral signal has been observed around VSs on postcontrast 3D FLAIR imaging. The incidence and characterization of this finding have not yet been assessed in a systematic study, however, and the mechanism for this finding also remains unexplored. This study sought to further define this radiologic finding by evaluating peritumoral FLAIR signal in a cohort of patients with treatment-naïve sporadic vestibular schwannomas.

MATERIALS AND METHODS

Patient Selection

This study was performed following approval by the local institutional review board. A retrospective radiologic review was completed of a random sample of 20 patients diagnosed with a presumed vestibular schwannoma (based on imaging findings). The size of the patient cohort (n = 20) was chosen as a number deemed sufficient to achieve the goal of this study: to confirm anecdotal evidence of the presence of peritumoral post-FLAIR signal in patients with treatment-naïve VSs to establish it as a potential biomarker for future study. Neither the size nor the appearance of VSs was used as an inclusion criterion for the studied cohort.

All patients underwent dedicated IAC MR imaging between October 11, 2017, and November 23, 2021. No examinations required exclusion for artifacts such as motion. In addition, to assess precontrast FLAIR images in the same patient cohort, we completed a review of MR imaging performed before the included study with precontrast FLAIR images performed through the IAC. As noted in the results, precontrast FLAIR images were available for evaluation in 16/20 patients. Demographic information was assessed using a review of the electronic medical record.

MR Imaging Parameters

A 3T Siemens scanner (Magnetom Prisma) with multichannel phased array coils was used to image all patients (with either a 32- or a 64-channel head coil). Dedicated IAC imaging was performed using axial 3D T1 sampling perfection with application-optimized contrasts by using different flip angle evolution (SPACE sequence; Siemens) (TR = 600 ms, TE = 32 ms, data matrix = 192 × 192, acquisition time = 4 minutes 0 second), axial 3D T2 SPACE (TR = 1300 ms, TE = 184 ms, data matrix = 320 × 320, acquisition time = 3 minutes 55 seconds), axial 3D fat-saturated postcontrast T1 SPACE (TR = 600 ms, TE = 32 ms, data matrix = 192 × 192, acquisition time = 4 minutes 0 second), and axial 3D postcontrast FLAIR (TR = 5000 ms, TE = 379 ms, data matrix = 192 × 192, acquisition time = 4 minutes 29 seconds). The FOV for each sequence was 150 mm.

Imaging Review

A blinded retrospective review was performed by 2 Certificate of Added Qualification–certified neuroradiologists (J.C.B., J.I.L.). All VSs were evaluated for laterality, location, and size. Location was categorized as being completely within the IAC, completely in the CPA, or in both the IAC and CPA. Size was based on the largest single axial dimension. For VSs located in both the IAC and CPA, only the largest dimension of the CPA component was measured, in accordance with reporting guidelines.14 Fundal cleft size was assessed by measuring between the lateral-most aspect of the VS and the IAC fundus. Obstruction of the fundus from the remainder of the IAC and/or CPA by the VS was assessed using axial T2 SPACE images; obstruction was defined as a region of complete occlusion of the IAC by the tumor.

The presence or absence of peritumoral signal on FLAIR images (here referred to as the peritumoral “halo”) was assessed by fusing and overlaying axial postcontrast FLAIR images with both axial fat-saturated postcontrast T1W1 and axial T2 SPACE images using the institutional PACS system. The difference in tumor size between these images was used to measure the thickness of the halo, if present. Image subtraction was also used to better define the differences between both the tumor margins and the halo. Only 1 MR imaging examination was assessed per patient; changes across serial examinations were not evaluated as part of this study.

In addition, the maximum signal intensity of specified areas was measured on postcontrast FLAIR images: the ipsilateral fundus (if a cleft was present) and the ipsilateral cochlea. Free-form ROIs were used for each measurement to precisely outline these anatomic structures. The contralateral fundus and cochlea were also measured to provide internal reference. The ipsilateral and contralateral signal intensities were compared using the statistical methods outlined below. Each measurement was obtained using our institution’s PACS system.

Any interobserver disagreements regarding the presence or absence of a halo or abnormal signal in the fundus were resolved by consensus. For the measured thickness of the halo, the average measurement between observers was used.

Statistical Analyses

Means and SDs were calculated for all continuous variables. Statistical calculations were performed using BlueSky Statistics software (https://www.blueskystatistics.com/). The Student t test was used to calculate statistical differences among continuous variables. The Cohen κ was used to calculate interobserver agreement with categoric variables, and Bland-Altman plots were used to calculate interobserver agreement with continuous variables. The threshold for statistical significance was set at P < .05.

RESULTS

Twenty patients were included; 11/20 (55.0%) were women, and the average age was 69.5 years (SD, 10.2). Eleven VSs (55.0%) were located on the right; 16/20 tumors (80.0%) were located entirely within the IAC, while 4 exhibited CPA extension of the tumor. None of the observed VSs were isolated to the CPA. The average size of all tumors was 5.8 (SD, 3.1) mm (Table). A fundal cleft was present in 16 patients (80.0%). The average size of the fundal cleft, when present, was 2.3 (SD, 1.8) mm. Of the patients with a fundal cleft, the VS obstructed the fundus in 5 patients (38.5%). In patients with a nonobstructed fundus, the tumor was either smaller than the diameter of the IAC or the tumor was centered along one wall of the IAC with a patent CSF cleft on the other side.

View this table:
  • View inline
  • View popup

Sizes and incidence of multiple imaging findings

Hyperintense peritumoral signal (halo) was present on postcontrast FLAIR images in 90% of patients. In general, the observed halo was nonuniform in thickness around the circumference of the tumors (Fig 1). The halo itself was difficult to confirm as being outside the tumor borders without the use of overlay/fused images in the PACS system. The average maximum thickness of the halo in the axial plane was 1.0 (SD, 0.2) mm. Interobserver agreement regarding the presence or absence of a halo was nearly perfect (κ = 0.95), while the interobserver correlation coefficient of the halo thickness was 0.38.

FIG 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 1.

Example of a peritumoral halo on postcontrast FLAIR images. Postcontrast fat-saturated T1-weighted image (A) demonstrates a vestibular schwannoma extending from the right IAC into the CPA. Postcontrast FLAIR image (B) shows a discontinuous peritumoral hyperintense halo that extends beyond the tumor margins on postcontrast T1-weighted images (arrows). Corresponding subtraction FLAIR image (C) confirms the presence of a halo (arrows).

Regarding the 2 tumors that lacked a halo, one was 14 mm and the other was 8 mm. The 14-mm tumor lacked a fundal cleft, potentially affecting the ability to visualize a peritumoral halo. Both fusion and subtraction on the 8-mm tumor were somewhat difficult, possibly affecting the ability to visualize a halo in that lesion.

Sixteen patients had prior MR imaging with precontrast FLAIR imaging of the IAC available for review (the average time between prior and current MR imaging was 62.9 [SD, 24.6] months). None of these studies (0%) showed abnormal peritumoral signal on precontrast FLAIR images.

Of patients with a fundal cleft, hyperintense signal was observed in the fundus on postcontrast FLAIR images in 13 of 16 (82.3%). Ten of those 13 patients had tumoral obstruction of the fundus. Interobserver agreement for observation of a fundal cleft signal was moderate (κ = 0.46). On average, the maximum signal in the ipsilateral fundus on postcontrast FLAIR images was 205.9 (SD, 110.2), which was significantly greater than the average signal in the contralateral fundus (121.6 [SD, 27.8]) (P = .02).

Pathologically increased FLAIR signal was subjectively observed in the ipsilateral cochleae structures in 10 patients (50.0%) (Fig 2). Of those 10 patients, the fundal cleft was obstructed in 6. On postcontrast FLAIR images, the mean measured maximum intracochlear signal (167.8 [SD, 104.5]), on average, was greater than contralateral cochlear signal (113.4 [SD, 40.1]) (P = .04).

FIG 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 2.

Multiple findings of possible gadolinium leakage from a vestibular schwannoma. Fused axial T2 SPACE and postcontrast T2 FLAIR image (A) shows a vestibular schwannoma centered in the left porus acusticus with a peritumoral halo (arrows) that extends past the solid tumor borders. Hyperintense signal was observed in the ipsilateral IAC fundus and asymmetrically elevated signal in the ipsilateral cochlea on the postcontrast T2 FLAIR image (B). Noncontrast FLAIR image on a prior study (C) does not show abnormal peritumoral signal, indicating that this finding should not represent peritumoral edema.

DISCUSSION

This study assessed the incidence of peritumoral signal on postcontrast FLAIR images in a cohort of patients with vestibular schwannoma. We found that a previously undescribed peritumoral halo was observed in a high proportion of cases, typically measuring about 1 mm in maximum thickness. This halo is difficult to detect without the use of coregistered/fused images or image subtraction. Asymmetrically elevated postcontrast FLAIR signal was also present in both the fundus and ipsilateral cochlea, confirming the findings of prior studies.

The most logical explanation for the observed findings is that the hyperintense halo represents extratumoral leakage of gadolinium, because it was not demonstrated on any precontrast FLAIR images. The presence of halos on postcontrast FLAIR images, but not postcontrast T1WI, could be due to ≥1 factor. It is possible that leakage is better visualized on FLAIR images because of superior sensitivity to the T1-shortening effect of gadolinium.15,16 It is also possible that the FLAIR images better depicted gadolinium leakage because they were acquired later in the imaging protocol, allowing interval leaching of contrast into the peritumoral space.

Because the halos were nonuniform in appearance and not circumferential peritumoral rings, we hypothesize that the early gadolinium leakage becomes trapped in a peritumoral space created by the enveloping arachnoid or within cysts and/or adhesions. As seen during microsurgical tumor dissection, VSs are surrounded by a thin, irregular, arachnoid layer that is variably adherent to the tumor surface. Additionally, peritumoral cysts have been well-documented previously,17 and vestibular schwannomas specifically are known to exist in an inflammatory microenvironment.18 Thus gadolinium may have become caught in the veil of the peritumoral arachnoid or peritumoral cysts before leaking further into the adjacent CSF. Elevated signal in the ipsilateral fundus and cochlea suggests that additional leakage does occur, possibly in a more diluted manner than the halo effect.

It is not clear why the leaked contrast seems to be locally transported and/or resorbed in the ipsilateral cochlea, even in cases in which the IAC is not occluded. It is possible that even partial occlusion of the IAC (or underlying anatomic constraints of the IAC structure) leads to somewhat stagnant flow of leaked gadolinium into the adjacent CSF, which then, preferentially, is concentrated in the adjacent cochlea rather than diffusing more broadly into the CSF. Altogether, the precise pathophysiology of the observed findings is likely even more complex than what we have outlined, and it is possible that the halo sign is not specific to VS. Further studies using larger cohorts and a greater variety of tumors should help to develop a more comprehensive model.

The concept of VS contrast extravasation is not new. VSs have previously been hypothesized to leak gadolinium into the adjacent structures, most notably the ipsilateral cochlea. Yamazaki et al,19 for example, found that ipsilateral cochleae have higher signal intensity on postcontrast FLAIR. In that study, the authors demonstrated a convincing increase in intracochlear signal intensity on postcontrast FLAIR images compared with precontrast images, and gadolinium leakage into the IAC fundus. This increased ipsilateral cochlear signal on postcontrast FLAIR signal has been assessed elsewhere.20 The authors contended that the intracochlear signal was suggestive of increased permeability of the blood-labyrinthine barrier in the setting of a VS.19 Most interesting, Fig 3 in the article of Yamazaki et al also seems to show a peritumoral halo on postcontrast FLAIR images, though neither fused nor subtraction images were shown. The finding was not discussed by the authors.

Pathologically elevated signal is known to be present in the ipsilateral cochlea of patients with VSs on precontrast FLAIR imaging. Unlike the cochlear enhancement observed by Yamazaki et al,19 this intrinsic T2/FLAIR hyperintensity in the cochlea is attributed to elevated well-documented protein in the perilymph.21,22 Historically, labyrinthine taps to test for proteinaceous fluid were used as a diagnostic test for VSs.23 Although the cause of increased perilymphatic protein remains unknown, the mechanism favored by many authors is the blockage of neuroaxonal protein transportation, related to compression of the vestibulocochlear nerve.21

Conceivably, the detection of elevated protein seen on FLAIR and gadolinium in the fundus and labyrinth may be related to the tumor obstructing the IAC and creating a relatively stagnant small reservoir of CSF. In this setting, low levels of leached protein or contrast from the tumor may accumulate to sufficient levels to be detected. This possibility may explain the relative gradient seen in FLAIR and gadolinium, with higher concentrations often occurring in the fundus adjacent to the tumor compared with the labyrinth. In contrast, any tumor or contrast leaked medially into the relatively large CPA cistern will naturally dilute and recirculate in the ∼125 mL of CSF in the remaining subarachnoid space, which turns over approximately 3 times daily. Prior literature has identified elevated levels of circulating CSF protein in individuals with small vestibular schwannomas and associated communicating hydrocephalus, implicating protein sludging as a mechanism for reduced CSF resorption.24

Finally, a very recent publication proposed that peritumoral “rim” enhancement on FLAIR could help differentiate meningiomas from malignant dural-based tumors.25 The rim of peritumoral contrast shown in that study is very similar to the halo we describe in the current findings. The authors of that study opined that the observed findings were due to the dual blood supply (meningeal and pial) of meningiomas. This supply led to relative intratumoral signal loss on FLAIR (due to T2 shortening in the setting of high gadolinium concentrations) and relatively hyperintense signal in the pial-supplied tumor capsule. The results of the current study, however, seem to refute the findings of this recent publication. Most important, vestibular schwannomas are nonencapsulated tumors and do not have a dual blood supply.26 Also, as previously stated, the halos observed in the current study are irregular and do not appear to conform to a smooth capsule. Last, enhancement of a tumor capsule would not explain the more diffuse gradient that seems to occur in our cohort, in which gadolinium appears to accumulate in the fundus and cochlea. Together, we believe that these findings are evidence of gadolinium leakage, as stated above.

The results of this current study leave many questions unanswered, and future studies will be needed for further exploration. For example, the incidence and/or appearance of peritumoral halos may vary among patients with sporadic VSs compared with VSs related to neurofibromatosis type 2, or in untreated-versus-treated tumors. It may also be useful to determine whether the presence of a peritumoral halo predicts the stability or growth of a tumor. At present, these topics are outside of the scope of the current study.

This study has several limitations, including being a retrospective review. The goal of defining the radiologic finding of a peritumoral halo is somewhat limited in scope, and the results of this study are preliminary and based on a small cohort. Additional studies using large sample sizes will be needed to confirm these findings, as well as to assess the clinical relevance. In addition, many of the VSs analyzed in this study were relatively small. Future studies will also be needed to address whether tumor size has an impact on the thickness and/or appearance of a peritumoral halo. Also, the precontrast FLAIR images that were available for review were part of separate MR imaging examinations. Thus, no precontrast FLAIR imaging was available for direct comparison with postcontrast FLAIR in this study. Finally, the proposed mechanisms for the observed peritumoral halo are hypothetical and based on limited prior studies. It is possible that the peritumoral signal on postcontrast FLAIR images simply represents an imaging artifact. Also, because the average halo thickness was around 1 mm, the precision of the reported measurements may be questionable, given the pixel size on standard PACS calipers.

CONCLUSIONS

A peritumoral halo on postcontrast FLAIR images was observed in nearly all vestibular schwannomas in our cohort of 20 patients, usually measuring about 1 mm in thickness. Although the pathophysiologic mechanism of this finding is uncertain, we hypothesize that this halo may represent local leakage of gadolinium into the peritumoral space.

Footnotes

  • Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org.

References

  1. 1.↵
    1. Lin EP,
    2. Crane BT
    . The management and imaging of vestibular schwannomas. AJNR Am J Neuroradiol 2017;38:2034–43 doi:10.3174/ajnr.A5213 pmid:28546250
    Abstract/FREE Full Text
  2. 2.↵
    1. Marinelli JP,
    2. Beeler CJ,
    3. Carlson ML, et al
    . Global incidence of sporadic vestibular schwannoma: a systematic review. Otolaryngol Head Neck Surg 2022;167:209–14 doi:10.1177/01945998211042006 pmid:34464224
    CrossRefPubMed
  3. 3.↵
    1. Fukuda M,
    2. Oishi M,
    3. Kawaguchi T, et al
    . Etiopathological factors related to hydrocephalus associated with vestibular schwannoma. Neurosurgery 2007;61:1186–92; discussion 1192–93 doi:10.1227/01.neu.0000306096.61012.22 pmid:18162897
    CrossRefPubMed
  4. 4.↵
    1. Lewis D,
    2. Roncaroli F,
    3. Agushi E, et al
    . Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma. Neuro Oncol 2019;21:314–25 doi:10.1093/neuonc/noy177 pmid:30388263
    CrossRefPubMed
  5. 5.↵
    1. Gurewitz J,
    2. Schnurman Z,
    3. Nakamura A, et al
    . Hearing loss and volumetric growth rate in untreated vestibular schwannoma. J Neurosurg 2022;136:768–75 doi:10.3171/2021.2.JNS203609 pmid:34416729
    CrossRefPubMed
  6. 6.↵
    1. Luryi AL,
    2. Babu S,
    3. Bojrab DI, et al
    . Progression of hearing loss in observed non-growing vestibular schwannoma. Otol Neurotol 2022;43:e767–72 doi:10.1097/MAO.0000000000003563 pmid:35763454
    CrossRefPubMed
  7. 7.↵
    1. Connor SE
    . Imaging of the vestibular schwannoma: diagnosis, monitoring, and treatment planning. Neuroimaging Clin N Am 2021;31:451–71 doi:10.1016/j.nic.2021.05.006 pmid:34689927
    CrossRefPubMed
  8. 8.↵
    1. Bonneville F,
    2. Savatovsky J,
    3. Chiras J
    . Imaging of cerebellopontine angle lesions: an update, Part 1: enhancing extra-axial lesions. Eur Radiol 2007;17:2472–78 doi:10.1007/s00330-007-0679-x pmid:17562049
    CrossRefPubMed
  9. 9.↵
    1. Thamburaj K,
    2. Radhakrishnan VV,
    3. Thomas B, et al
    . Intratumoral microhemorrhages on T2*-weighted gradient-echo imaging helps differentiate vestibular schwannoma from meningioma. AJNR Am J Neuroradiol 2008;29:552–57 doi:10.3174/ajnr.A0887 pmid:18079187
    CrossRefPubMed
  10. 10.↵
    1. Giordano M,
    2. Gerganov V,
    3. Metwali H, et al
    . Imaging features and classification of peritumoral edema in vestibular schwannoma. Neuroradiol J 2020;33:169–73 doi:10.1177/1971400919896253 pmid:31840570
    CrossRefPubMed
  11. 11.↵
    1. Welby JP,
    2. Benson JC,
    3. Lohse CM, et al
    . Increased labyrinthine T1 postgadolinium signal intensity is associated with the degree of ipsilateral sensorineural hearing loss in patients with sporadic vestibular schwannoma. AJNR Am J Neuroradiol 2023;44:317–22 doi:10.3174/ajnr.A7800 pmid:36797029
    Abstract/FREE Full Text
  12. 12.↵
    1. Cass ND,
    2. Fan Y,
    3. Lindquist NR, et al
    . Automated whole cochlear T2 signal demonstrates weak correlation with hearing loss in observed vestibular schwannoma. Audiol Neurootol 20231–11 doi:10.1159/000530567 pmid:37321181
    CrossRefPubMed
  13. 13.↵
    1. Bowen AJ,
    2. Carlson ML,
    3. Lane JI
    . Inner ear enhancement with delayed 3D-FLAIR MRI imaging in vestibular schwannoma. Otol Neurotol 2020;41:1274–79 doi:10.1097/MAO.0000000000002768 pmid:32925857
    CrossRefPubMed
  14. 14.↵
    Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma); American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg. 1995;113:179–80 doi:10.1016/S0194-5998(95)70101-X pmid:7675475
    CrossRefPubMed
  15. 15.↵
    1. Mathews VP,
    2. Caldemeyer KS,
    3. Lowe MJ, et al
    . Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology 1999;211:257–63 doi:10.1148/radiology.211.1.r99mr25257 pmid:10189481
    CrossRefPubMed
  16. 16.↵
    1. Mahale A,
    2. Choudhary S,
    3. Ullal S, et al
    . Postcontrast fluid-attenuated inversion recovery (FLAIR) sequence MR imaging in detecting intracranial pathology. Radiol Res Pract 2020;2020:8853597 doi:10.1155/2020/8853597 pmid:33123380
    CrossRefPubMed
  17. 17.↵
    1. Herde RF,
    2. Hoang N,
    3. Tran DK, et al
    . Peritumoral cysts associated with pituitary macroadenoma. J Neurosurg 2015;123:789–93 doi:10.3171/2014.12.JNS141031 pmid:26140485
    CrossRefPubMed
  18. 18.↵
    1. Hannan CJ,
    2. Lewis D,
    3. O’Leary C, et al
    . The inflammatory microenvironment in vestibular schwannoma. Neurooncol Adv 2020;2:vdaa023 doi:10.1093/noajnl/vdaa023 pmid:32642684
    CrossRefPubMed
  19. 19.↵
    1. Yamazaki M,
    2. Naganawa S,
    3. Kawai H, et al
    . Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma. Neuroradiology 2009;51:855–63 doi:10.1007/s00234-009-0588-6 pmid:19727694
    CrossRefPubMed
  20. 20.↵
    1. Naganawa S,
    2. Komada T,
    3. Fukatsu H, et al
    . Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla. Eur Radiol 2006;16:733–37 doi:10.1007/s00330-005-0046-8 pmid:16267664
    CrossRefPubMed
  21. 21.↵
    1. Kim DY,
    2. Lee JH,
    3. Goh MJ, et al
    . Clinical significance of an increased cochlear 3D fluid-attenuated inversion recovery signal intensity on an MR imaging examination in patients with acoustic neuroma. AJNR Am J Neuroradiol 2014;35:1825–29 doi:10.3174/ajnr.A3936 pmid:24742808
    Abstract/FREE Full Text
  22. 22.↵
    1. Bhadelia RA,
    2. Tedesco KL,
    3. Hwang S, et al
    . Increased cochlear fluid-attenuated inversion recovery signal in patients with vestibular schwannoma. AJNR Am J Neuroradiol 2008;29:720–23 doi:10.3174/ajnr.A0968 pmid:18238842
    CrossRefPubMed
  23. 23.↵
    1. Silverstein H
    . Labyrinthine tap as a diagnostic test for acoustic neurinoma. Otolaryngol Clin North Am 1973;6:229–44
    CrossRefPubMed
  24. 24.↵
    1. Al Hinai Q,
    2. Zeitouni A,
    3. Sirhan D, et al
    . Communicating hydrocephalus and vestibular schwannomas: etiology, treatment, and long-term follow-up. J Neurol Surg B Skull Base 2013;74:68–74 doi:10.1055/s-0033-1333621 pmid:24436891
    CrossRefPubMed
  25. 25.↵
    1. Panyaping T,
    2. Punpichet M,
    3. Tunlayadechanont P, et al
    . Usefulness of a rim-enhancing pattern on the contrast-enhanced 3D-FLAIR sequence and MRI characteristics for distinguishing meningioma and malignant dural-based tumor. AJNR Am J Neuroradiol 2023;44:247–53 doi:10.3174/ajnr.A7780 pmid:36732030
    Abstract/FREE Full Text
  26. 26.↵
    1. Kuo TC,
    2. Jackler RK,
    3. Wong K, et al
    . Are acoustic neuromas encapsulated tumors? Otolaryngol Head Neck Surg 1997;117:606–09 doi:10.1016/S0194-59989770040-8 pmid:9419086
    CrossRefPubMed
  • Received May 15, 2023.
  • Accepted after revision August 3, 2023.
  • © 2023 by American Journal of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 44 (10)
American Journal of Neuroradiology
Vol. 44, Issue 10
1 Oct 2023
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Peritumoral Signal on Postcontrast FLAIR Images: Description and Proposed Biomechanism in Vestibular Schwannomas
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
John C. Benson, Matt L. Carlson, John I. Lane
Peritumoral Signal on Postcontrast FLAIR Images: Description and Proposed Biomechanism in Vestibular Schwannomas
American Journal of Neuroradiology Oct 2023, 44 (10) 1171-1175; DOI: 10.3174/ajnr.A7979

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Peritumoral Signal in Vestibular Schwannomas
John C. Benson, Matt L. Carlson, John I. Lane
American Journal of Neuroradiology Oct 2023, 44 (10) 1171-1175; DOI: 10.3174/ajnr.A7979
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSIONS
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Vestibular Schwannoma-Related Increased Labyrinthine Postgadolinium 3D-FLAIR Signal Intensity and Association with Hearing Impairment
  • The "Outline Sign": Thin Hyperenhancing Perimeter as an MR Imaging Feature of Meningioma. A Useful Tool in the Temporal Bone Region for Differentiating Meningiomas from Schwannomas and Paragangliomas
  • Imaging Findings Post-Stereotactic Radiosurgery for Vestibular Schwannoma: A Primer for the Radiologist
  • Crossref (3)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Imaging Findings Post-Stereotactic Radiosurgery for Vestibular Schwannoma: A Primer for the Radiologist
    Girish Bathla, Parv M. Mehta, John C. Benson, Amit K. Agrwal, Neetu Soni, Michael J. Link, Matthew L. Carlson, John I. Lane
    American Journal of Neuroradiology 2024 45 9
  • Vestibular Schwannoma–Related Increased Labyrinthine Postgadolinium 3D-FLAIR Signal Intensity and Association with Hearing Impairment
    John P. Welby, Nicholas M. Baumel, Ghazal S. Daher, Armine Kocharyan, Christine M. Lohse, Girish Bathla, Matthew L. Carlson, John I. Lane, John C. Benson
    American Journal of Neuroradiology 2025 46 3
  • The “Outline Sign”: Thin Hyperenhancing Perimeter as an MR Imaging Feature of Meningioma. A Useful Tool in the Temporal Bone Region for Differentiating Meningiomas from Schwannomas and Paragangliomas
    Anil K. Vasireddi, Katherine L. Reinshagen, Donghoon Shin, Laura V. Romo, Amy F. Juliano
    American Journal of Neuroradiology 2025 46 2

More in this TOC Section

  • WHO Classification Update: Nasal&Skull Base Tumors
  • Chondrosarcoma vs Synovial Chondromatosis: Imaging
Show more HEAD & NECK

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editors Choice
  • Fellow Journal Club
  • Letters to the Editor

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • Special Collections

Resources

  • News and Updates
  • Turn around Times
  • Submit a Manuscript
  • Author Policies
  • Manuscript Submission Guidelines
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Submit a Case
  • Become a Reviewer/Academy of Reviewers
  • Get Peer Review Credit from Publons

Multimedia

  • AJNR Podcast
  • AJNR SCANtastic
  • Video Articles

About Us

  • About AJNR
  • Editorial Board
  • Not an AJNR Subscriber? Join Now
  • Alerts
  • Feedback
  • Advertise with us
  • Librarian Resources
  • Permissions
  • Terms and Conditions

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire